| Leesha Peoples, CRNA | |
|
1505 Eastland Dr, Ll 1400, Bloomington, IL 61701-3534 | |
| (309) 663-4700 | |
| (309) 665-0575 |
| Full Name | Leesha Peoples |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 30 Years |
| Location | 1505 Eastland Dr, Bloomington, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831175843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 041217553 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Pain Services Llc | 6507930526 | 26 |
News Archive
Five Star Quality Care, Inc. today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC of Richardson, TX.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).
"The Intellectual Property & Science division of Thomson Reuters on Tuesday announced the publication of a new study tracking the current status of research on neglected tropical diseases [NTDs]," a Thomson Reuters Corporation press release reports.
› Verified 9 days ago
| Entity Name | Midwest Anesthesia Consultants, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790963114 PECOS PAC ID: 1951487172 Enrollment ID: O20080327000424 |
News Archive
Five Star Quality Care, Inc. today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC of Richardson, TX.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).
"The Intellectual Property & Science division of Thomson Reuters on Tuesday announced the publication of a new study tracking the current status of research on neglected tropical diseases [NTDs]," a Thomson Reuters Corporation press release reports.
› Verified 9 days ago
| Entity Name | Anesthesia Pain Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790075489 PECOS PAC ID: 6507930526 Enrollment ID: O20080808000180 |
News Archive
Five Star Quality Care, Inc. today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC of Richardson, TX.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).
"The Intellectual Property & Science division of Thomson Reuters on Tuesday announced the publication of a new study tracking the current status of research on neglected tropical diseases [NTDs]," a Thomson Reuters Corporation press release reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leesha Peoples, CRNA 1505 Eastland Dr, Ll 1400, Bloomington, IL 61701-3534 Ph: (309) 663-4700 | Leesha Peoples, CRNA 1505 Eastland Dr, Ll 1400, Bloomington, IL 61701-3534 Ph: (309) 663-4700 |
News Archive
Five Star Quality Care, Inc. today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC of Richardson, TX.
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.
Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).
"The Intellectual Property & Science division of Thomson Reuters on Tuesday announced the publication of a new study tracking the current status of research on neglected tropical diseases [NTDs]," a Thomson Reuters Corporation press release reports.
› Verified 9 days ago
Mr. Thomas Eric Laver, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 11 Ann Arbor Ct, Bloomington, IL 61705 Phone: 312-388-4440 | |
Kaitlyn E Busch, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2200 E Washington St, Bloomington, IL 61701 Phone: 309-662-3311 | |
Julie R Heisel-wolter, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr, Suite Ll 1400, Bloomington, IL 61701 Phone: 309-663-4700 Fax: 309-665-0575 | |
Gregory R Dubois, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr, Ll 1400, Bloomington, IL 61701 Phone: 309-663-4700 Fax: 309-665-0575 | |
Jason Richard Huber, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2022 E Taylor St, Bloomington, IL 61701 Phone: 309-264-4571 | |
Mi H Balgemann, DNP, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2200 E Washington St, Bloomington, IL 61701 Phone: 309-662-3311 | |
Nachelle Richard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr, Ll1400, Bloomington, IL 61701 Phone: 309-663-4700 Fax: 309-665-0575 |